Jupiter, Florida, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL ™, a patented ...
Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer’s diseaseClear and ...
SAN DIEGO--(BUSINESS WIRE)--Nuvie Bio, a new clinical-stage biopharmaceutical company dedicated to addressing the most pressing unmet medical needs in migraine and related neurological diseases, ...
Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to ...
Vigil Neuroscience, Inc. has announced its financial results for Q1 2025 and provided updates on its clinical trials. The company is on track to report the final analysis from its Phase 2 IGNITE trial ...
Aidoc, the leading clinical AI platform, today announced strategic partnerships with Cercare Medical and Circle CVI to expand ...
Modern day science tends to be highly interdisciplinary. It increasingly requires different technical topics, skills, and expertise to come together to solve complex and challenging problems and ...
Before the pandemic forced remote work, school and research to the forefront, decentralized clinical trials were probably on the horizon. Now, they’re here in earnest. This week, precision psychiatry ...
Neuroscience is a vast field of study containing a range of narrower subfields. Each involves a spotlight on the brain and other parts of the nervous system, connecting them to one or more zones of ...
Neuroscience is a vast field of study containing a range of narrower subfields. Each involves a spotlight on the brain and other parts of the nervous system, connecting them to one or more zones of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback